Atorvastatin API: Statin for Cholesterol Control and CV Risk Reduction

Introduction to Atorvastatin API

Atorvastatin is a lipid‑lowering agent belonging to the statin class. It is prescribed to reduce elevated total cholesterol, LDL‑cholesterol, and triglycerides, and to decrease cardiovascular risk in high‑risk patients. As an API, Atorvastatin is primarily used for film‑coated tablet formulations.

Key Indications

• Primary hypercholesterolemia and mixed dyslipidemia
• Prevention of cardiovascular events in patients with multiple risk factors
• Adjunctive therapy in familial hypercholesterolemia

Mechanism of Action

Atorvastatin selectively inhibits HMG‑CoA reductase, the rate‑limiting enzyme in hepatic cholesterol synthesis. This leads to up‑regulation of LDL receptors and enhanced clearance of LDL‑cholesterol from the bloodstream, thereby reducing atherosclerotic risk.

API Quality and Formulation Notes

Atorvastatin is typically used as the calcium salt and is sensitive to moisture and light. Careful control of polymorphic form, particle size, and degradation impurities is necessary. Packaging should protect against humidity, and formulations often employ stabilisers to maintain potency throughout shelf‑life.